← Eichor
Study identifier: NCT05494346 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Condition: Acute Rhinitis · Nasal Obstruction · Rhinosinusitis  ·  Sponsor: Laboratoires Gilbert

PhaseNA
Planned participants101
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this pre-market clinical investigation is to assess the safety and the performance of decongestant seawater spray pocket valve enriched with essential oils by Gilbert Laboratories. The study will evaluate the results of acute rhinitis associated with nasal obstruction using the decongestant seawaterspray pocket valve enriched with essential oils over a 8 day period.

This description comes directly from the study's public registry record.

Talk to the study team

Carine BRUNEL  ·  +33 (0)1 45 39 50 21  ·  cbrunel@labogilbert.fr

Always discuss trial participation with your own doctor first.

Locations (5)

Cabinet MédicalBlainville-sur-Orne, FranceRecruiting
Cabinet Médical CaenCaen, FranceRecruiting
MSP du Haut AnjouChâteauneuf-sur-Sarthe, FranceRecruiting
Cabinet Médical GainnevilleGainneville, FranceWithdrawn
ALYATECStrasbourg, FranceCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05494346